On March 4th, 2011 – FDASmart Inc (NY,USA) will host a one-day forum on “Pharmaceutical Anti-Counterfeiting in Emerging Regions: Who’s Winning the Battle”.
According to the Center for Medicine in the Public Interest, counterfeit drug sales are expected to reach $75 billion globally by 2010 – skyrocketing by 90% from the 2005 level.
Reported counterfeit incidents in recent past involved 112 countries and 639 branded, generic, and over-the-counter (OTC) drugs, according to the
Pharmaceutical Security Institute -- and most instances go unreported because “you don’t know what you don’t know.
This unique one-day forum brings together international and local Indian stakeholders from the pharmaceutical industry, government and leading pharma associations in India to address the number one problem : the war against drug counterfeits !
On March 4th in Mumbai, we will present the latest developments on the rapidly growing ,global drug counterfeiting scenario in emerging regions, discuss the root causes that drive counterfeiting in underdeveloped regions,then present a thesis that a multi-level & multi-stakeholder, simultaneous joint effort is mandatory in order to successfully combat anti-counterfeiting .
Recently, the Foreign Trade Ministry of India made an announcement: that Exporter of Pharmaceutical products will build track and trace capability for their exported medicines using barcode technology with GS 1 global standards by July 2011 to protect and ensure that India’s global generic industry continue with its reputation as the “pharmacy to the world”.
